Tyenne Injection, Solution
Product Images NDC 65219-586

Product Visual Gallery

This gallery contains 64 technical images submitted to the FDA as part of the official labeling for Tyenne (NDC 65219-586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tye01 0000 01)

A line graph depicting the percentage of patients achieving ACR20 response over various visit weeks (2 to 24), comparing three treatment groups: Placebo + MTX, Tocilizumab 8 mg/kg + MTX, and Tocilizumab 4 mg/kg + MTX. The y-axis represents the percentage with standard error bars, and the x-axis shows visit weeks.*

FDA Label Image

Figure (Tye01 0000 02)

An instructional illustration panel for TYENNE (tocilizumab-aazg) injection 162 mg/0.9 mL subcutaneous single-dose autoinjector. The panel emphasizes reading instructions carefully before use, showing an image of the autoinjector device on a purple background.*

FDA Label Image

Figure (Tye01 0000 03)

An illustration showing the labeled parts of a TYENNE injection pen for subcutaneous administration. The diagram identifies the clear cap, window, medicine inside the pen, and the body of the pen, depicting the components of the 162 mg/0.9 mL Tocilizumab-aazg injection device by Fresenius Kabi USA, LLC.*

FDA Label Image

Figure (Tye01 0000 04)

Illustration diagram of a subcutaneous injection pen showing labeled parts including needle cover, window, body, and plunger rod. The image highlights the components of the device intended for administering the medication.*

FDA Label Image

Figure (Tye01 0000 05)

An instructional graphic panel labeled Step 1 with the text "Prepare for your injection" on a purple and orange background, indicating the first step in injection preparation instructions.*

FDA Label Image

Figure (Tye01 0000 06)

Illustration showing a sharps disposal container labeled "Sharps Disposal" with accompanying items including an alcohol pad and a sterile cotton ball, likely intended for safe subcutaneous injection practices.*

FDA Label Image

Figure (Tye01 0000 07)

Illustration showing a close-up view of a briefcase or carton with an expiration date label marked as 'EAP: YYYY-MM'. This figure appears to emphasize the location or format of the expiration date on the product packaging, likely for the TYENNE Tocilizumab-aazg 162 mg/.9 mL subcutaneous injection by Fresenius Kabi USA, LLC.*

FDA Label Image

Figure (Tye01 0000 08)

Instructional illustration labeled Figure C showing a tray with a covered injection device and a clock indicating a 45-minute interval, likely representing a waiting or preparation time related to the drug administration process.*

FDA Label Image

Figure (Tye01 0000 09)

An instructional illustration showing a hand holding a TYENNE injection device above the open palm of the other hand, likely demonstrating how to hold or prepare the subcutaneous injection for administration.*

FDA Label Image

Figure (Tye01 0000 10)

An instructional graphic labeled Step 2, displaying a purple background with white text advising to check your autoinjector. The left side features an orange arrow pointing to the right with text 'Step 2' in white. This image appears to be part of a multi-step guide for autoinjector use.*

FDA Label Image

Figure (Tye01 0000 11)

Illustration labeled Figure E depicting a medical syringe with a protective cap, focusing on the injection device's plunger and needle cover. The image shows the detailed design of the syringe tip and cap, presumably to assist with proper usage or preparation of the injection.*

FDA Label Image

Figure (Tye01 0000 12)

Figure F is a close-up illustration focusing on the expiration date area of a label or vial of TYENNE, a subcutaneous injection solution containing 162 mg/0.9 mL of Tocilizumab-aazg by Fresenius Kabi USA, LLC. The expiration date is shown as a placeholder text 'EXP: YYYY-MM'.*

FDA Label Image

Figure (Tye01 0000 13)

An instructional illustration showing the correct and incorrect appearance of a solution inside a syringe. The 'Correct' image depicts a syringe with a clear solution and no visible particles. The 'Incorrect' image shows particles present in the syringe solution. The figure is labeled 'Particles Figure G.'*

FDA Label Image

Figure (Tye01 0000 14)

An instructional graphic labeled "Step 3" showing the text "Wash your hands" on a purple background with an orange arrow pointing right. This image is part of a procedural or hygiene instruction set.*

FDA Label Image

Figure (Tye01 0000 15)

Illustration labeled "Figure H" showing a person washing their hands under a faucet with running water and soap suds, demonstrating hand hygiene procedures.*

FDA Label Image

Figure (Tye01 0000 16)

Instructional graphic labeled "Step 4" showing the text "Choose the injection site" on a purple background, bordered by an orange triangle on the left. It appears to be part of a step-by-step guide for administering an injection.*

FDA Label Image

Figure (Tye01 0000 17)

Illustration showing recommended injection sites for the subcutaneous injection of TYENNE (tocilizumab-aazg). Areas marked in purple indicate sites suitable for self or caregiver administration, located on the abdomen and front thighs. Areas marked in red indicate sites for caregiver-only administration, located on the upper arms at the back.*

FDA Label Image

Figure (Tye01 0000 18)

An instructional banner labeled 'Step 5' featuring the text 'Clean the injection site' on a purple background with an orange arrow section highlighting the step number.*

FDA Label Image

Figure (Tye01 0000 19)

An instructional illustration labeled "Figure J" depicting a hand administering a subcutaneous injection into the upper thigh area, demonstrating the proper technique for giving a subcutaneous injection.*

FDA Label Image

Figure (Tye01 0000 20)

Instructional step labeled 'Step 6 Give your injection' displayed on a segmented rectangular banner with orange and purple backgrounds, indicating a stage in a process for administering an injection. No product packaging or drug details are shown.*

FDA Label Image

Figure (Tye01 0000 21)

An instructional illustration showing a hand removing an orange cap from a syringe or injection device, with a purple arrow pointing upward indicating the direction to remove the cap. Labeled as Figure K.*

FDA Label Image

Figure (Tye01 0000 22)

An instructional illustration showing a hand holding a syringe or injection pen at a 90-degree angle to the skin surface, indicating the proper technique for subcutaneous injection.*

FDA Label Image

Figure (Tye01 0000 23)

An instructional diagram showing a hand holding a prefilled syringe. An arrow points to the plunger with the instruction 'CLICK at start' and another arrow below the syringe instructs to 'KEEP HOLDING DOWN,' indicating injection technique steps likely related to subcutaneous administration.*

FDA Label Image

Figure (Tye01 0000 24)

An instructional illustration showing part of the administration process for a subcutaneous injection. It depicts a hand holding an injection device and an arrow indicating the user should wait for 10 seconds after the 2nd click, with accompanying text instructing to keep holding down during this time.*

FDA Label Image

Figure (Tye01 0000 25)

An instructional illustration showing a hand holding a syringe with an arrow pointing downward. The figure includes the text 'WAIT' with a 5-second timer, indicating a waiting step in the injection process.*

FDA Label Image

Figure (Tye01 0000 26)

An instructional illustration labeled 'Figure P' showing an eye and an adjacent injection device. The image depicts a horizontal dashed line connecting the eye to the orange-tipped injection syringe, likely indicating the proper eye-level positioning for the injection.*

FDA Label Image

Figure (Tye01 0000 27)

An instructional graphic labeled 'Step 7' with the directive to 'Remove and check the autoinjector,' indicating part of a step-by-step guide for using an autoinjector device.*

FDA Label Image

Figure (Tye01 0000 28)

An instructional illustration showing a hand pulling the cap off a prefilled syringe or injection pen, with an upward arrow indicating the removal direction. The device is held above an arm, indicating preparation for subcutaneous injection.*

FDA Label Image

Figure (Tye01 0000 29)

An illustration showing a hand holding a syringe with an orange plunger, demonstrating a step related to injection preparation or administration, labeled as Figure R.*

FDA Label Image

Figure (Tye01 0000 30)

An instructional diagram showing a hand pinching the skin of an arm at a bent elbow, indicating preparation for a subcutaneous injection.*

FDA Label Image

Figure (Tye01 0000 31)

An instructional graphic showing "Step 8" with the text "Throw away your autoinjector." The design includes a purple rectangular background with white text and an orange arrow pointing right with the step number. This is part of usage or disposal instructions for an autoinjector device.*

FDA Label Image

Figure (Tye01 0000 32)

Illustration showing proper disposal of a syringe into a container labeled 'Sharps Disposal.' A hand is depicted placing a syringe into the sharps container, emphasizing safe disposal practices for injection devices.*

FDA Label Image

Figure (Tye01 0000 33)

Instructional image panel titled 'Step 9' with the text 'Record date of administration and injection site' displayed on an orange and purple gradient background, emphasizing documentation during the injection process.*

FDA Label Image

Figure (Tye01 0000 34)

An instructional illustration showing a hand holding a syringe preparing to inject in the left thigh. The image includes a label area for recording the date of administration and injection site, filled with the example date 11/24/22.*

FDA Label Image

Figure (Tye01 0000 35)

Instructions for Use illustration showing a prefilled single-dose syringe of TYENNE injection, containing 162 mg/0.9 mL of tocilizumab-aazg for subcutaneous use. The image includes a labeled syringe highlighting its use instructions.*

FDA Label Image

Figure (Tye01 0000 36)

An instructional diagram showing a TYENNE 162 mg/0.9 mL subcutaneous injection syringe before and after use. The diagram labels syringe components including needle cap, clear needle guard, barrel containing liquid solution, plunger, finger flange, expiration date on back, and the extended needle guard spring after use.*

FDA Label Image

Figure (Tye01 0000 37)

An instructional banner with the text 'Step 1 Prepare for your injection' displayed on a gradient purple background with an orange arrow on the left side, indicating the first step in a multi-step injection preparation process.*

FDA Label Image

Figure (Tye01 0000 38)

An instructional diagram showing components for administering TYENNE (Tocilizumab-aazg) 162 mg/0.9 mL subcutaneous injection. The labeled items include a sharps disposal container, an alcohol pad, a sterile cotton ball, and a TYENNE prefilled syringe, intended for safe injection procedure.*

FDA Label Image

Figure (Tye01 0000 39)

An instructional diagram showing a hand removing a small box from a refrigerator, followed by a close-up view indicating lifting a blue tab or flap on the box. This likely illustrates steps for handling or preparing the product before use.*

FDA Label Image

Figure (Tye01 0000 40)

Figure D is a circular illustration with a clock face showing the text '30 min' inside, indicating a 30-minute time duration. The clock's outline and hour marks are purple, with no additional text or detailed instructions visible in the image.*

FDA Label Image

Figure (Tye01 0000 41)

Instructional graphic titled 'Step 2 Check the syringe' with a purple background and an orange arrow pointing right. It is part of a guide focusing on syringe preparation or verification steps for medication administration.*

FDA Label Image

Figure (Tye01 0000 42)

Instructional diagram showing a hand holding a prefilled syringe labeled TYENNE (tocilizumab-aazg) with an orange safety cap, positioned above an injection site or surface, with an upward purple arrow indicating removal or lifting action (Figure E).*

FDA Label Image

Figure (Tye01 0000 43)

Illustration showing a labeled vial of TYENNE (tocilizumab-aazg) injection, solution, 162 mg/0.9 mL. The vial label includes product name, strength, dosage form, and placeholders for lot number and expiration date (EXP: YYYY-MM). The image highlights the vial's labeling for subcutaneous injection.*

FDA Label Image

Figure (Tye01 0000 44)

An instructional diagram depicting a syringe labeled with 'Tyenne.' The diagram highlights the label area on the syringe barrel, illustrating where the product name is displayed for user identification.*

FDA Label Image

Figure (Tye01 0000 45)

An instructional diagram showing the proper handling and use of a Tyenne 162 mg/0.9 mL subcutaneous injection syringe. The figures illustrate correct positioning and actions for injection use, including proper syringe orientation and plunger handling, with visual indicators for correct (green check marks) and incorrect (red X) techniques.*

FDA Label Image

Figure (Tye01 0000 46)

Instructional banner image displaying 'Step 3 Wash your hands' with a purple background and an orange arrow pointing right. It is part of a multi-step instructional guide related to medication use or preparation.*

FDA Label Image

Figure (Tye01 0000 47)

An instructional illustration showing hands being washed under a faucet with running water and soap. This hygiene-related image is likely part of usage or preparation instructions for a subcutaneous injection product.*

FDA Label Image

Figure (Tye01 0000 48)

An instructional graphic titled 'Step 4 Choose the injection site' in white text on a purple background with an orange arrow pointing left bearing 'Step 4' in white text. It appears to be part of a stepwise guide, likely related to administering an injection.*

FDA Label Image

Figure (Tye01 0000 49)

An instructional diagram showing recommended subcutaneous injection sites for TYENNE (tocilizumab-aazg) 162 mg/0.9 mL solution. The front view highlights the abdomen and outer thighs for self or caregiver injection. The back view indicates the upper arms for caregiver-only injections, using color coding to distinguish site options.*

FDA Label Image

Figure (Tye01 0000 50)

Instructional graphic labeled Step 5, titled 'Clean the injection site,' featuring a purple background. This image is part of a stepwise guide related to injection preparation or administration.*

FDA Label Image

Figure (Tye01 0000 51)

An instructional diagram panel labeled "Step 6" with the directive "Give your injection." The panel has a purple background and includes a purple arrow pointing right with white text, indicating the sixth step in a multi-step instructional sequence for administering an injection.*

FDA Label Image

Figure (Tye01 0000 52)

An instructional illustration showing a hand removing the cap from a syringe prefilled with a solution, depicted by an arrow pointing upward from the cap. The syringe is held with an orange thumb rest and contains a liquid, consistent with subcutaneous injection preparation.*

FDA Label Image

Figure (Tye01 0000 53)

An instructional illustration showing a hand holding a syringe, poised to administer an injection. The syringe is oriented with the needle pointing upward and a plunger being pressed, demonstrating injection technique for subcutaneous administration.*

FDA Label Image

Figure (Tye01 0000 54)

An instructional illustration labeled Figure P showing a hand pinching the skin, likely demonstrating a technique related to subcutaneous injection.*

FDA Label Image

Figure (Tye01 0000 55)

An instructional illustration showing a hand holding a syringe at a 45-degree angle with an arrow indicating injection into the forearm. The image emphasizes avoiding a 90-degree angle injection.*

FDA Label Image

Figure (Tye01 0000 56)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the skin of a finger. The image emphasizes correct needle insertion angle and hand positioning, likely related to the administration of TYENNE (tocilizumab-aazg) injection, solution.*

FDA Label Image

Figure (Tye01 0000 57)

An instructional illustration showing the proper technique for removing the needle cap from a syringe. The image highlights holding the syringe in one hand and carefully pulling the orange needle cap straight off with the other hand, emphasizing safe needle handling.*

FDA Label Image

Figure (Tye01 0000 58)

An instructional illustration showing a hand holding a TYENNE injection pen for subcutaneous use. The image demonstrates removing the cap from the injection device prior to use, highlighting the step with a close-up view of the cap being pulled off. The figure is labeled Figure T.*

FDA Label Image

Figure (Tye01 0000 59)

Illustration step labeled 'Step 7' instructing to throw away the used prefilled syringe. The background is a gradient from orange to purple with white text.*

FDA Label Image

Figure (Tye01 0000 60)

An instructional illustration showing a hand holding a syringe with an orange cap, positioned above a sharps disposal container labeled "Sharps Disposal." A downward purple arrow indicates the action of disposing of the syringe into the container.*

FDA Label Image

Figure (Tye01 0000 61)

Instructional banner labeled 'Step 8 Record your injection' with an orange arrow pointing right and a purple background. This step likely guides users to document their injection process as part of a multi-step injection procedure.*

FDA Label Image

Figure (Tye01 0000 62)

An illustration shows a hand holding a pencil poised over a blank sheet of paper, as if preparing to write or draw. The image has a simple, clean style with a focus on the hand and pencil.*

FDA Label Image

Principal Display Panel – 162 mg/0.9 mL Autoinjector (Tye01 0000 63)

Packaging label for TYENNE 162 mg/0.9 mL injectable solution containing Tocilizumab-aazg. The label indicates a single-dose autoinjector for subcutaneous use only. The product is manufactured by Fresenius Kabi USA, LLC. The label features dosage and storage instructions, active and inactive ingredient information, and a barcode.*

FDA Label Image

Principal Display Panel – 162 mg/0.9 mL Prefilled Syringe (Tye01 0000 64)

Carton label for TYENNE 162 mg/0.9 mL subcutaneous injection, Tocilizumab-aazg, by Fresenius Kabi USA, LLC. The packaging indicates a single-dose prefilled syringe and includes storage, dosage, and ingredient information, with prominent blue, orange, and white color scheme and company logos.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.